Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors

Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors

Introduction: Malignant brain tumors in infants less than 12 months of age are extremely rare, and they have poor prognosis. We evaluated genetic characteristics and response rates of infants with congenital brain tumors subjected to high-dose chemotherapy and autologous stem cell transplant after g...

Full description

Bibliographic Details
Main Authors: Milena Guidi, Laura Giunti, Anna Maria Buccoliero, Mariarita Santi, Barbara Spacca, Salvatore De Masi, Lorenzo Genitori, Iacopo Sardi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Pediatrics
Subjects:
congenital tumor
chemotherapy
glioblastoma
brain tumor
newborn
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.00135/full

Similar Items

Similar Items